UBS Investors Are Aiming to Make ‘Competitive’ Returns From a Fund Related to Cancer
Global investors are always looking for the next best place to put their cash to get decent returns — and this time it looks like many are looking towards the healthcare sector for bumper profits.
Now it’s not as sinister as it sounds.
Basically investors stump up huge amounts of cash, and put it into a fund that aims to develop cancer treatments. In return they aim to get a sizeable profit on their investments.
And it is with this in mind that UBS Wealth Management just raised a record $471 million (£323 million) from investors for its UBS Oncology Impact Fund.